Related Experiment Video

Updated: Aug 15, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

[Primary prevention of coronary heart disease with aspirin]

W Kübler1, H Darius

  • 1Klinikum Neukölln, Vivantes-Netzwerk für Gesundheit, I. Med. Klinik, Berlin, Germany.

Zeitschrift Fur Kardiologie
|November 1, 2005
PubMed

Insights

Aspirin effectively prevents coronary heart disease but carries risks like bleeding. Its use in primary prevention depends on individual coronary heart disease risk factors.

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Pharmacology

Context:

  • Coronary heart disease (CHD) remains a leading cause of mortality globally.
  • Primary prevention strategies aim to reduce the incidence of first-time CHD events.
  • Aspirin's role in primary prevention is debated due to a balance of benefits and risks.

Purpose:

  • To evaluate the efficacy and safety of aspirin for primary prevention of coronary heart disease.
  • To determine the threshold of coronary heart disease risk for initiating aspirin therapy.
  • To discuss potential complications of aspirin therapy in primary prevention.

Summary:

  • Meta-analyses and high-power studies indicate aspirin is effective in primary prevention of coronary heart disease (CHD).
  • However, benefits are offset by increased risks of gastrointestinal bleeding and hemorrhagic stroke.
  • Aspirin is recommended for individuals with an annual CHD risk of 1.5% or higher, with discussion advised for risks between 0.7%-1.4%.

Impact:

  • Provides evidence-based guidance on aspirin use for primary CHD prevention.
  • Highlights the importance of personalized risk assessment in clinical decision-making.
  • Suggests potential implications of aspirin resistance and paradox in primary prevention settings.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...